Amira Afifi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Amira Afifi has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Eman S Elgharabawy
Medical Microbiology and Immunology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt
1 shared publication - Ghada Amr
Zagazig University Faculty of Medicine, Clinical Pathology, 10 Elfardos Street, Hai Elsalam, Zagazig, Egypt
1 shared publication - Mahmoud M. Magdy
Internal Medicine Department, Al‐Sabah Hospital, Shuwaikh Industrial, Kuwait
1 shared publication - Mai M. Malek
Medical Microbiology and Immunology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt
1 shared publication - Rawan Hamada
Alqumia, nour elhoda street, zagazig, alsharquia, Egypt
1 shared publication - Rehab Mohamed Ateya
Clinical Pathology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt
1 shared publication
Latest Publications
- Open Access
- 31 December 2022
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 16 (12) , 1852-1859
Susceptibility of carbapenem-resistant Enterobacterales isolates to new antibiotics from a tertiary care hospital, Egypt: A matter of hope
Introduction: Carbapenem-resistant Enterobacterales (CRE) are particularly worrisome pathogens because of their resistance to last-resort antibiotics, significant morbidity, and mortality. With limited treatment options, new therapeutic choices have become available for the management of CRE infections. Data regarding the efficacy of these novel agents are still limited particularly in a low-middle-income country like Egypt. This study aims to assess the prevalence of different carbapenemase genes among CRE isolates and the susceptibility of these isolates to novel antibiotics for improving antibiotic policy and infection control strategies in Egypt. Methodology: In this cross-sectional study, 260 Enterobacterales were recovered from patients admitted to intensive care units between January and June 2021. Susceptibility testing was conducted using Kirby-Bauer method. Molecular detection of five carbapenemase genes, namely blaKPC, blaIMP, blaVIM, blaNDM, blaOXA-48 was done using polymerase chain reaction (PCR). Results: Of the 260 Enterobacterales, 34.6% were found to be carbapenems resistant. All of the CRE isolates were multi-drug resistant exhibiting resistance to most antibiotics. All isolates harbored one or more carbapenemases genes. The most prevalent was blaNDM (84.4%), followed by blaOXA-48 (73.3%), blaKPC (13.3%), blaIMP (2.2%), while blaVIM gene wasn’t detected. Among 62.2% of the CRE isolates, two or more carbapenemase genes co-existed. For the new antibiotics tested, 100% of CRE resisted ceftolozane/tazobactam, 86.7% resisted ceftazidime/avibactam, 51.1% were resistant to eravacyclin, and 42.2% were resistant to cefiderocol. Conclusions: A high percentage of resistance to carbapenems among Enterobacterales isolates was revealed. blaNDM was found to be the most predominant carbapenemase gene. A high rate of CRE resistance to novel agents signifies a major threat.
- 31 December 2022
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 16 (12) , 1852-1859
Open AccessSusceptibility of carbapenem-resistant Enterobacterales isolates to new antibiotics from a tertiary care hospital, Egypt: A matter of hope
Introduction: Carbapenem-resistant Enterobacterales (CRE) are particularly worrisome pathogens because of their resistance to last-resort antibiotics, significant morbidity, and mortality. With limited treatment options, new therapeutic choices have become available for the management of CRE infections. Data regarding the efficacy of these novel agents are still limited particularly in a low-middle-income country like Egypt. This study aims to assess the prevalence of different carbapenemase genes among CRE isolates and the susceptibility of these isolates to novel antibiotics for improving antibiotic policy and infection control strategies in Egypt. Methodology: In this cross-sectional study, 260 Enterobacterales were recovered from patients admitted to intensive care units between January and June 2021. Susceptibility testing was conducted using Kirby-Bauer method. Molecular detection of five carbapenemase genes, namely blaKPC, blaIMP, blaVIM, blaNDM, blaOXA-48 was done using polymerase chain reaction (PCR). Results: Of the 260 Enterobacterales, 34.6% were found to be carbapenems resistant. All of the CRE isolates were multi-drug resistant exhibiting resistance to most antibiotics. All isolates harbored one or more carbapenemases genes. The most prevalent was blaNDM (84.4%), followed by blaOXA-48 (73.3%), blaKPC (13.3%), blaIMP (2.2%), while blaVIM gene wasn’t detected. Among 62.2% of the CRE isolates, two or more carbapenemase genes co-existed. For the new antibiotics tested, 100% of CRE resisted ceftolozane/tazobactam, 86.7% resisted ceftazidime/avibactam, 51.1% were resistant to eravacyclin, and 42.2% were resistant to cefiderocol. Conclusions: A high percentage of resistance to carbapenems among Enterobacterales isolates was revealed. blaNDM was found to be the most predominant carbapenemase gene. A high rate of CRE resistance to novel agents signifies a major threat.
- 23 August 2022
- Published by Egyptian Knowledge Bank in Zagazig University Medical Journal
Presepsin versus Delta Lactate in Diagnosis of Sepsis in Intensive Care Unit
Background: Sepsis is a worldwide health problem; it is considered as a form of organ dysfunction. The aim of this study was to identify the role of presepsin in diagnosis of sepsis in ICU patients and its relation to the delta lactate level. Methods: 46 adult participants were included in the study that was conducted at the clinical pathology department and the Intensive Care Unit (ICU) of zagazig university hospitals. The septic group included patients more than 18 years old with positive sepsis criteria that included; temperature > 38°c or < 36°c, leucocytes >12,000/mm3 or < 4000/mm3, heart rate>90bpm or respiratory rate>20 breaths/min. The non-septic group included healthy control individuals above 18 years old. Demographic data were collected from patients. All patients in this study were subjected to presepsin, CRP and WBCs count measurement. Delta lactate was measured using two lactate measurements. Results: We included 31 patients in the septic group; 64.5% (20 participants) of them were males and 15 participants in the non-septic group; 53.3% (8 participants) of them were males. Comparing the two groups regarding sepsis biomarkers; there was a highly significant difference regarding WBCs and CRP with a p-value of
- 23 August 2022
- Published by Egyptian Knowledge Bank in Zagazig University Medical Journal
Presepsin versus Delta Lactate in Diagnosis of Sepsis in Intensive Care Unit
Background: Sepsis is a worldwide health problem; it is considered as a form of organ dysfunction. The aim of this study was to identify the role of presepsin in diagnosis of sepsis in ICU patients and its relation to the delta lactate level. Methods: 46 adult participants were included in the study that was conducted at the clinical pathology department and the Intensive Care Unit (ICU) of zagazig university hospitals. The septic group included patients more than 18 years old with positive sepsis criteria that included; temperature > 38°c or < 36°c, leucocytes >12,000/mm3 or < 4000/mm3, heart rate>90bpm or respiratory rate>20 breaths/min. The non-septic group included healthy control individuals above 18 years old. Demographic data were collected from patients. All patients in this study were subjected to presepsin, CRP and WBCs count measurement. Delta lactate was measured using two lactate measurements. Results: We included 31 patients in the septic group; 64.5% (20 participants) of them were males and 15 participants in the non-septic group; 53.3% (8 participants) of them were males. Comparing the two groups regarding sepsis biomarkers; there was a highly significant difference regarding WBCs and CRP with a p-value of